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Available online 10 September 2018Background: Diagnostic Task Force Criteria (TFC) for arrhythmogenic cardiomyopathy (AC) exhibit poor perfor-
mance for left dominant forms. TFC only include right ventricular (RV) dysfunction (akinesia, dyssynchrony,
volumes and ejection fraction). Moreover, cardiac magnetic resonance imaging (CMRI) assessment of left ventric-
ular (LV) dyssynchrony has hitherto not been described. Thus,we aimed to comprehensively characterize LVCMRI
behavior in AC patients.
Methods: Thirty-five AC patients with LV involvement and twenty-three non-affected family members (controls)
were enrolled. Feature-tracking analysis was applied to cine CMRI to assess LV ejection fraction (LVEF), LV end-
systolic and end-diastolic volume indexes, strain values and dyssynchrony. Regions with more frequent strain
and dyssynchrony impairment were also studied.
Results: Radial dyssynchrony and LVEF were selected (sensitivities 54.3% and 48.6%, respectively at 100% specific-
ity),with a threshold of 70ms for radial dyssynchrony and48.5% for LVEF. 71.4% of patients exceeded these thresh-
olds (31.4% both, 22.9% only dyssynchrony and 17.1% only LVEF). Considering these cut-off values as a novel
combined criterion, 30% of patientswith ‘borderline’ or ‘possible’AC following 2010 TFCwouldmove to a ‘definite’
AC diagnosis. Strainwas globally impairedwhereas dyssynchronous regionsweremore often apical and located at
the inferolateral wall.
Conclusions:Mirroring the RV evaluation, we suggest including LVEF and LV dyssynchrony to improve the diagno-
sis of AC. Two independentmechanisms can be claimed in AC patientswith LV involvement: 1) decreasedmyocar-
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Arrhythmogenic cardiomyopathy (AC) is an inherited rare disease
characterized by a progressive myocardial fibrofatty replacement [1,2].
It is associated with heart failure and life-threatening arrhythmias
being one of the leading causes of sudden death in young people [3].
In the classic description, structural changes involved only the right
ventricular (RV) myocardium and may extend to the left ventricular
(LV) muscle in advanced forms. Its incomplete penetrance and variable
phenotypic expression [2,4] hampers its diagnosis evenwith the scoring
system stablished in the Task Force Criteria (TFC) in 1994 [5]. Once leftthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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LV involvement were implemented in the revised version in 2010
(negative T waves in V4-6 as a minor criterion for repolarization
abnormalities) [8]. Individually, each criterion has a high specificity at
the expense of a low sensitivity, yielding good performance in the global
assessment proposed by the 2010 TFC [9].
Although cardiacmagnetic resonance imaging (CMR) provides com-
prehensive information on cardiac morphology, function, and tissue
characterization [10] [11], the 2010 TFC do not include a non-invasive
tissue evaluation based on late gadolinium enhancement (LGE) analysis
and it does limit the global and regional dysfunction evaluation just to
the right ventricle, both in terms of RV motility (akinesia and/or
dyssynchrony without specific thresholds) and volume-related perfor-
mance (RV end-diastolic volume to body surface area and decreased
RV ejection fraction-EF).
Multiple commercial software tools implement feature-tracking algo-
rithms for CMR strain and dyssynchrony assessment, including Medis
Qstrain (Medis Medical Imaging Systems, Leiden, the Netherlands),
TomTec (Tom-Tec Imaging Systems, Unterschleissheim, Germany) or
Circle Cardiovascular Imaging (CVI42 , Calgary, Canada), among others.
Ventricular dyssynchrony has been studied in patients with electrical
and structural heart diseases [12–15] using echocardiography, CMR and
nuclear imaging [15,16] with reasonable agreement among them
[17,18]. Particularly, RV dyssynchrony has been shown to be higher in
classical forms of AC, either with echocardiography [19] or with CMR
[20,21]. Beyond its diagnostic potential, impaired strain measurements
also correlate with a poor prognosis [22].
The aim of the present study is three-fold. Firstly, we describe for the
first time LV dysfunction in AC patients with LV involvement from CMR
analysis by means of: peak strain, dyssynchrony, LV ejection fraction
(LVEF), and LV end-diastolic and end-systolic volume indexes (LVEDVi
and LVESVi, respectively). Secondly, we report our cut-off values at
100% specificity and the subsequent reallocation of patients in the TFC
categories after applying them. Finally, we explore the LV regions
most prone to suffering from wall motion abnormalities.
We hypothesize that: 1) AC patients with LV involvementmight ex-
hibit less strain, more profound LV dyssynchrony, impaired LVEF and
greater LVEDVi and LVESVi than controls; 2) To detect LV involvement,
novel CMR criteria with appropriate thresholds would reclassify
borderline and/or possible AC patients to definite AC and 3) LVwallmo-
tion abnormalities may match against LGE regions, i.e. the inferolateral
wall.
2. Material and methods
2.1. Datasets
Thirty-five individuals diagnosed with AC with LV involvement (patients)
and twenty-three non-affected family members (controls) were enrolled at a dedicated
clinic.
Patients were included when a pathogenic/probably pathogenic mutation in AC-
related genes was identified and the typical intramyocardial/subepicardial pattern of
LGEwas observed. Additionally, patients belonged to 17 families inwhichAChad beenun-
equivocally identified (either histologically at autopsy or at heart transplantation and/or
with ‘definite’ 2010 TFC criteria) in at least one family member and a good phenotype-
genotype cosegregation had been confirmed. Thus, provided a typical LGE pattern was
considered amajor criterion, all these patientswould fulfill a definite diagnosis of AC (pos-
itive for at least two major criteria). To characterize ventricular predominance in AC in-
volvement, we applied the scoring system previously reported by our group [23].
From 14 families, controls were obtained as non-affected family members who
attended the screening program, with no CMR sign of AC and no carriers of the mutation
identified in affected relatives.
The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki, was
approved by the institution's research ethics committee, and all subjects gave their in-
formed consent.
CMR studies were performed in 1.5-Tesla scanners (Siemens Avanto, Siemens
Symphony or GE Signa HDxt). Cine long-axis slices (two-, three- and four-chamber
view) and a stack of contiguous cine short-axis slices from the atrioventricular ring
to the LV apex were acquired using a steady-state free precession pulse sequence
(20–25 phases per cardiac cycle, 6–8 mm slice thickness, no interslice gap, 360
× 480 field of view, 196 × 172 matrix size).2.2. Feature tracking
Endocardial (without papillary muscles) and epicardial contours of the LV at the end-
diastole were traced semi-automatically in the four cardiac chamber view. The automated
tissue tracking algorithm (Circle CVI42 version 5.5.1, Calgary, Canada) was applied to ob-
tain radial, circumferential and longitudinal strain curves for each of the LV American
Heart Association segments, except for the apex (segment 17). Strain measurements are
defined as:




where L(ti) stands for radial/circumferential/longitudinal lengths measured at each LV
segment at the time corresponding to the ith frame, where L0 is the length measured
from the initial frame. Consequently, the strain curvesmeasure the temporal degree of de-
formation at each of the radial, circumferential and longitudinal axes. Time-to-peak was
assessed as the time at which the strain curve reached its maximum. Fig. 1A shows radial
strain curves and time-to-peak measurements.
2.3. Global LV alterations
Global strain valueswere computed as themean peak strain whereas dyssynchronies
were computed as the standard deviation of the time-to-peak, always in the three axes
and in each of the 16 LV segments. The LVEF was computed from the endocardial
(endo) volume curves:
EF ¼ Vendo tDð Þ−Vendo tSð Þ
Vendo tDð Þ
where Vendo(ts) stands for end-systolic volume and Vendo(tD) for end-diastolic volume [24].
End-diastolic and end-systolic volume indexes were calculated dividing the volumes by
the body surface area according to the Du Bois formula [25].
2.4. Regional LV alterations
Wall motion abnormalities and the presence of LGE were qualitatively identified by
highly-trained CMR experts. Additionally, a quantitative regional LV wall motion abnor-
mality assessment was performed with t-tests comparing the individual peak strain and
time-to-peak values at each region between controls and a subset of patients with mark-
edly hypokinetic or dyssynchronic behavior since their global strain or their global
dyssynchrony were below or above cut-off values, respectively.
2.5. Statistical analysis
Dichotomous variables are presented as percentages and compared with the chi-
square test between clinical groups. Continuous variables with a normal distribution are
presented as mean ± SD and compared with the Student t-test between clinical groups.
Pearson's test was used for correlation assessments.
To be consistent with TFC, we maximized specificity for each individual criterion.
Firstly, we selected the parameters with significant differences between patients and con-
trols. The statistical p-values were Bonferroni-corrected to avoid spurious associations, as
multiple comparisons were carried out (p-values b0.05 were considered statistically sig-
nificant). We then constructed the Receiver Operating Characteristic curves and extracted
the cut-off points for 100% specificity. All statistics were obtained with the statistical soft-
ware SPSS (version 23.0 for Windows, SPSS Inc., Chicago, Illinois).
3. Results
3.1. Clinical and demographic features
Among clinical and demographic characteristics sex, arterial hyper-
tension, ischemic heart disease and dyslipemia were similar in both
groups (Table 1). However, controls were older andmore often diabetic
than patients (p b 0.05).
Twenty-two out of the 35 AC patients presented isolated LV involve-
ment, whereas 13 exhibited biventricular AC. ‘Definite AC’ according to
the 2010TFCwas diagnosed in 69%, ‘borderline inAC’ in 11%and ‘possible
AC’ in up to 20% of patients since they fulfilled only one major criteria
(mutation carriers), even though all subjects exhibited LVmyocardial in-
volvement to some extent with a typical LV LGE pattern. As expected,
mutations were regularly identified in the desmoplakin gene (82.8%),
with an infrequent representation of other genes, such as filamin C, des-
min, plakophillin-2 and phospholamban (Table 1, Online Table 1).
Fig. 1. Global and regional strain analyses. Example of the time-to-peak and peak radial strain of the 16 American Heart Association (AHA) segments (A). Quantitative regional analysis of
myocardial dysfunction in patients when compared with controls. The AHA segments with significant wall motion abnormalities are represented in grey since they exhibited delayed
time-to-peak (B) (B) and/or decreased strain values (not available for longitudinal analysis). Numbers refer to AHA classification.
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Notably, CMR studies from patients exhibited lower LVEF, radial, cir-
cumferential and longitudinal strain, but greater LVEDVi, LVESVi, radial
and circumferential dyssynchrony than controls, along with a non-
significant trend towards increased longitudinal dyssynchrony (Table 1,
Online Fig. 1). Our results showed that patients with AC with LV involve-
ment more often presented impaired LVEF (LVEF ≤55%) than enlarged
LVEDVi (LVEDVi N98 ml/m2) (71.4% versus 25.7%, respectively).
For the sake of clarity, we display the Receiver Operating Character-
istic curves in separate categories: volume-related variables (i.e. LVEF,
LVEDVi and LVESVi) in Fig. 2A; strain variables in Fig. 2B and
dyssynchrony parameters in Fig. 2C (only significant parameters were
considered). The variables with the best performance in each category
were LVEF (area under the curve-AUC = 0.85), longitudinal strain
(AUC = 0.85) and radial dyssynchrony (AUC = 0.78). The selected
cut-off values atmaximal specificitywere 48.5% for LVEF; 9.5% for longi-
tudinal strain and 70.0 ms for radial dyssynchrony (Fig. 2D).
3.3. Correlations between volume-related parameters, strain and
dyssynchrony variables
Volume and strain parameters were markedly correlated (LVEF
and circumferential strain: r = −0.959, p-value b0.01). Conversely,
dyssynchrony parameters were only moderately correlated with ei-
ther volume or strain-related parameters (radial dyssynchrony and
LVEF: r = −0.692; radial dyssynchrony and circumferential strain:
r = 0.705, p-value b0.01) (complete results in Online Table 2).
3.4. Reallocation of patients according to TFC stratification
The parameters with the best performance in terms of sensitivity
and AUCwere selected from Fig. 2D.We excluded circumferential strainfor this analysis due to its extremely high correlation with LVEF
(Online Table 2). Accordingly, we focused on LVEF (from among the
volume-related features) and radial dyssynchrony (from all three
dyssynchronies). Their cut-off points at maximal specificity were used
to build a contingency table with the percentage of patients in each cat-
egory (Online Table 3). Controls were excluded since they were all allo-
cated in the least affected categories, as these thresholds apply for 100%
specificity. As shown, 71.4% of patients presented abnormal values in at
least one parameter: 31.4% in both; 22.9% exclusively in radial
dyssynchrony, and 17.1% only in LVEF. Conversely, 28.6% of the patients
could not be detected after applying the proposed thresholds for LV
dysfunction.
Considering a LVEF b48.5% and/or a radial dyssynchrony N70ms as a
novel major criteria, 30% of AC patients previously classified as ‘border-
line’ or ‘possible’ categories according to 2010 TFC moved to a ‘definite’
AC diagnosis without affecting specificity. The bottom of Table 1 shows
the distribution of patients and controls in the categories published in
the 2010 TFC and with our suggested modification including LV dys-
function parameters.3.5. Regional LV alterations
Remarkably, regional wall motion abnormalities were qualitatively
seen in 30.3% of patients and usually involved the inferior and lateral
LV walls, precisely the same preferred localization as that observed for
the presence of LGE (Table 1). Furthermore, also in quantitative strain
measurements regional differences were observed in patients. Briefly,
the regional time-to-peak delays in radial and circumferential strain
were increased in patients when compared with controls, especially at
the inferolateral segments, whereas most of the basal segments were
preserved (Fig. 1B). On the contrary, strain was globally decreased in
the entire left ventricle, and only some basal segments maintained an
unaltered longitudinal strain when compared to controls (Fig. 1C).
Table 1
Clinical, demographic and CMR variables.
Total AC group with LV involvement (N = 35) Controls (N = 23) p-Value
Age 40.1 ± 17.9 49.6 ± 16.4 0.04
Sex (M/F) 16/19 10/13 0.87
Arterial hypertension 5 5 0.46
Diabetes mellitus 1 5 0.02*
Ischemic heart disease 0 1 0.21
Dyslipemia 9 7 0.69
Mutated gene††
Desmoplakin 29 (82.8%)1 0 –
Filamin C 1 (2.9%)2 0 –
Desmin 1 (2.9%)3 0 –
Plakophillin-2 1 (2.9%)4 0 –
Transmembrane protein 43 2 (5.8%)5 0 –
Phospholamban 1 (2.9%)6 0 –
LGE (%)
Location
Subepicardial 21 (58%) 0 –
Intramyocardial 8 (22%) 0






LVEDVi (ml/m2 ) 80.9 ± 24.7 65.4 ± 14.9 0.01*
LVEDVi N 98 ml/m2 (%) 25.7 4.3 0.072
LVESVi (ml/m2 ) 45.3 ± 23.1 26.3 ± 9.2 b0.001*
LVEF (%) 46.6 ± 11.1 60.5 ± 6.7 b0.001*
LVEF ≤ 55% (%) 71.4 21.7 b0.001*
LV wall motion abnormalities† (%)
Presence 30.3 0 –
Location
Inferolateral 73.0 –
Involving the anterior wall 23.0 –
Strain (%)
Radial 25.8 ± 9.9 40.5 ± 11.3 b0.001*
Circumferential −13.1 ± 3.5 −17.7 ± 2.6 b0.001*
Longitudinal −11.9 ± 2.9 −15.4 ± 2.0 b0.001*
Dyssynchrony (ms)
Radial 70.7 ± 26.4 46.1 ± 14.0 b0.001*
Circumferential 52.1 ± 15.5 38.6 ± 10.0 0.001*
Longitudinal 56.5 ± 24.5 47.3 ± 10.6 0.054
Total AC group with LV
involvement (N = 35)
AC with isolated LV
involvement (N = 22)
AC with biventricular





Definite AC 24 (69%) 12 12 0 –
Borderline AC 4 (11%) 4 0 1** –
Possible AC 7 (20%) 6 1 18** –
Proposed modification to 2010 TFC
Definite AC 27 (77%) 15 12 0 –
Borderline AC 2 (6%) 2 0 1** –
Possible AC 6 (17%) 5 1 18** –
*Bonferroni-corrected p-value b0.05. †Qualitative and visually detected. Please note that controls often fulfilled family history criteria because they were first degree relatives of a patient
with ‘definite’AC assessed by the 2010 TFC (**). Please note that 6 AC patients (5 carriers of radical and 1 non-radicalmutations) exhibited a second genetic hit (2 radical and 3 non-radical
mutations in AC-related genes and 1 a radical mutation in DMD gene possibly influencing in the cardiac phenotype) (†† ). 1 27 radical and 2 non-radical mutations, 2 1 radical mutation, 3 1
non-radical mutation, 4 1 radical mutation, 5 2 non-radical mutations, 6 1 radical mutation.
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a radial dyssynchrony of 80.1 ms.
4. Discussion
The study presented herein describes, for the first time, a detailed
pattern of LV dysfunction in AC patients with LV involvement. In sum,
we found that: 1) Patients exhibit impaired LV mechanical dispersion
and systolic function when compared with controls, 2) LVEF and radial
dyssynchrony are the most discriminant parameters with a joint sensi-
tivity of 71.4% (at least one parameter altered) for 100% specificity,
3) LVEF b48.5% and radial dyssynchrony N70 ms are the cut-off values
for the sample under study, 4) their addition to the current TFC correctly
reallocates 30% of the patients from ‘borderline’ and ‘possible’ AC to‘definite’ AC and 5) strain alterations are widespread in the whole LV,
whereas dyssynchronic patterns are regionally-restricted often to the
apical and inferolateral segments.4.1. Ventricular dysfunction assessment
Left ventricular ejection fraction has generally been considered ab-
normally depressed under 55% in AC patients as a sign of LV involve-
ment [2,6,26]. Papers focusing on AC with significant LV involvement
[6,26] reported a LVEF b55% in 24–56% of patients, whereas in our series
itwas slightly higher (71.4%, Table 1).With regard to LVvolumes, LV en-
largement was present in 26% of our AC patients with LV involvement
(LVEDVi N98 ml/m2 ), which is similar to the 24% previously reported
Fig. 2. Receiver-operating characteristic curves. Receiver-operating characteristic curves assessing the discriminative accuracy of volume (A) and strain (B, C) related parameters with
statistically significant differences between patients and controls. Volume related parameters: LVEF, LVEDVi and LVESVi. Strain related parameters: radial, circumferential and
longitudinal peak strain values and radial and circumferential dyssynchronies. Cut-off values and sensitivities for 100% specificity (D).
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specificity.
As expected, global strain parameters were notably correlated with
LVEF, thus the greater the deformation of the ventricle, the higher the
LVEF obtained. Consequently, strain values barely identified more pa-
tients than LVEF. Surprisingly, dyssynchrony values were correlated
with LVEF and strain to a lesser extent (Online Table 2) and allowed
us to consider them as complementary parameters to improve the de-
tection of LV involvement.
Some recent studies have assessed RV strain and dyssynchrony
among AC patients [19,21,27] identifying it also as a useful tool to
distinguish AC from idiopathic RV outflow tract arrhythmias [19] and
sarcoidosis [28,29].
4.2. Improving AC diagnosis
Historically, the right ventricle has been the key locationofAC involve-
ment, and thus plays a pivotal role in the 2010 TFC. With these criteria,
predominant LV involvement is difficult to diagnose. Following TFC ratio-
nale, we considered cut-off points so that a very high specificity is ob-
tained for each LV parameter, despite poor isolated sensitivity. The RV
cut-off points previously identified in the literature [27]were longitudinal
dyssynchrony N113.1 ms and circumferential dyssynchrony N177.1 ms,
with a sensitivity of 59% and 66% and a specificity of 95% and 83%, respec-
tively. In this study,we found increased LVdyssynchrony in radial and cir-
cumferential axes with cut-off values of radial dyssynchrony N70 ms andcircumferential dyssynchrony N55.6 ms, for 100% specificity and sensitiv-
ity levels of 54.3% and31.4%, respectively (Fig. 2D). Our dyssynchrony cut-
off values are notably lower than those reported for the right ventricle
[27], probably due to differences in RV and LV mechanical dispersion,
and also to lower specificities for a given RV cut-off (in accordance with
the published Receiver Operating Characteristic curves, sensitivity for
RV strain cut-offs decreases to under 22% when assessed for maximal
specificity [27],which ismuch less than the values reported in this study).
With the reported thresholds for LVEF and radial dyssynchrony as a
novel criterion to assess LV dysfunction, 30% of AC patients would move
from ‘borderline’ or ‘possible’ AC to ‘definite’ AC (Table 1). However, fur-
ther studies are needed to confirm our proposed criteria and to establish
more accurate cut-offs, depending on the desired percentage of detection.
Beyond its current role in TFC, CMR data may provide additional
valuable information regarding category I (ventricular global and re-
gional dysfunction, from cine analysis) and category II (tissue character-
ization, from LGE analysis). Adding our proposed combined criteria
would help to improve sensibility without losing specificity in the TFC
by assessing the left ventricle in category I.
4.3. Left ventricular regional alterations
Left ventricular wall motion abnormalities were not rare in our AC
patients (30.3%, Table 1), in accordancewith the reported data in the lit-
erature (40–80%) [2,6], and their presence was associated with lower
strain and/or higher dyssynchrony (Fig. 1B and C). The inferolateral LV
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plasia’ in AC patients, in conjunction with the subtricuspid region and
the RV outflow tract [30]. It has also been described as the typical loca-
tion of epicardial and/or intramyocardial LV LGE [6]. Consistentwith the
literature, our results indicate that the apical and inferolateral regions
were associated with LGE (Table 1) and also to dyssynchronous behav-
ior, whichwas extended to the anteroseptalwall in some cases (Table 1,
Fig. 1B). Contrary to expectations, the widespread distribution of the
hypokinetic regions (characterized by a globally decreased peak strain)
involved the entire left ventricle (Fig. 1C), unlike the localized
dyssynchronous abnormalities, and is thus poorly correlated. As a new
insight into the physiological substrates involved in AC, we posit that
the varying behavior of strain and dyssynchrony could depict different
information. More specifically, our results suggest two independent
mechanisms related to LV dysfunction. On the one hand, a globally de-
creasedmyocardial LV deformation, and on the other, a regional LV dys-
function with locally delayedmyocardial contraction at the inferolateral
apical wall associated with LGE areas. Patients with a definite AC diag-
nosis may exhibit these two mechanisms, only one of them, or neither.
These results open up new questions regarding the causes and implica-
tions of these mechanisms, e.g. which one is the earliest biomarker or
which one is associatedwith the highest ventricular arrhythmic burden.
The major contributions of this study are two-fold. Firstly, the nov-
elty of assessing LV strain in AC with LV involvement. The possibility
of introducing this approach in a modified TFC is, at least, tempting
and challenging. The second strength lies in the fact that controls were
not selected from the healthy general population, but insteadweremu-
tation negative non-affected family members of an AC proband. The
control group could be affected to some extent by other heart diseases,
whichmay go someway to explainingwhy nearly 22% of controls had a
LVEF ≤55%.
4.4. Limitations
In this research, only one feature tracking package was available. A
thorough validation of this approach should involve reproducibility
with other tools. Moreover, commercial packages are limited by the
fact that they have no FDA-approved feature tracking algorithms yet.
Therefore, these results can only be used for research purposes and can-
not be included in clinical practice.
Another limitation relates to the fact that we accepted the presence
of a typical LGE pattern as AC LV involvement. However, they were
young individualswithout other causes to explain that LGE pattern, har-
bored a pathogenic/probably pathogenicmutation in anAC related gene
(mostly a gene associated with LV involvement such as desmoplakin)
and belonged to families with a definite diagnosis of AC in at least in
one member. Thus, LV tissue involvement of AC was assumed from
LGE images even though it is not included in the current 2010 TFC. Inter-
estingly and out of the scope of the present study, it is possible that at an
earlier stage also mutation carriers without LGE could exhibit LV dys-
function. Future research endeavors focused on AC patients without
LGE and long follow up periods may validate this hypothesis.
We also acknowledge our reduced sample size. AC is regarded as a
rare disease and limiting the patient group to AC with LV involvement
and mutation positive individuals hampers the enrollment of patients
to an even greater extent.
Overall, renewed interest based upon our results may prompt fur-
ther studies to validate and fine-tune our approach by increasing the
sample, repeating the procedure with different feature tracking algo-
rithms and/or using other methodologies.
5. Conclusions
Strain analysis by feature tracking CMR helps to quantify global and
regional LV dysfunction, dyssynchrony and LVEF in AC patients with LV
involvement, a rare and lethal inherited cardiac disease. Radialdyssynchrony and LVEF were the variables with the most notable differ-
ences between patients and controls; while differences in circumferen-
tial dyssynchrony were also significant, though to a lesser extent. These
parameters could be assessed to improve the detection of ACwith LV in-
volvement in conjunction with other TFC categories. Unexpectedly, we
found regional discrepancies between strain and dyssynchrony analyses.
Whereas delayedmyocardial contraction was observed at the apical and
inferolateral segments, a globally decreasedmyocardial deformationwas
widespread throughout the left ventricle. These results suggest new
physiological pathways to improve the functional characterization and
diagnosis of AC with LV involvement.
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